Sanofi SA (SNY) reports a 7% revenue increase, with significant contributions from DUPIXENT and new product launches, despite ...

Sanofi stock jumped early Friday on better-than-expected third-quarter sales and earnings, and a strong showing from Dupixent ...

Health-care companies ticked up after a generally strong round of earnings. Hospital chain HCA Healthcare boosted its full-year growth outlook after logging higher profit and revenue in the third ...

The consensus analyst price target for Novavax stock has edged up from $12.50 to $13.21, reflecting an evolving outlook as the company navigates a transition in its business strategy. This shift ...

Medidata will be expanding its long-standing partnership with Sanofi, now leveraging Medidata Patient, Data, and Study Experiences within the collaboration. The ecosystem of tools aims to address ...

Thermo Fisher's stock offers attractive upside, backed by pharma recovery, margin expansion, and AI-driven efficiency. Read ...

Inhibrx Biosciences, Inc. reports strong phase 2 results for ozekibart in chondrosarcoma, with new cancer data and key ...

Fintel reports that on October 24, 2025, Cantor Fitzgerald initiated coverage of Novavax (NasdaqGS:NVAX) with a Overweight ...

Female sex is associated with up to 44% increased odds of chronic rhinosinusitis without nasal polyps (CRSsNP), but 37% ...

At the close, the Dow Jones Industrial Average was up 1.01% at 47,207.12, while the S&P 500 advanced 0.79% to 6,791.69, and ...

Tata Capital, Maruti Suzuki India, Urban Company, NTPC, Bank of Baroda and Cipla are among over 300 companies scheduled to ...

BEIJING, Oct. 25 (Xinhua) -- AstraZeneca's new global research and development (R&D) center was officially opened in the BioPark of the Beijing Economic-Technological Development Area (BDA) on ...